Phase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumab

Isla, D.Arriola, E.Garcia Campelo, M. R.Marti, C.Diz Tain, P.Moreno Vega, A. L.Piqueras, M. L-B.Leon, L.Gutierrez Calderon, V.Oramas Rodriguez, J. M.Majem, M.Sanchez-Hernandez, A.Aguado de la Rosa, C.Alvarez Cabellos, R.Marti-Ciriquian, J. L.Moreno Paul, A.Gonzalez Cordero, M.Callejo Mellen, A.Baez, L.Zugazagoitia, J.2023-05-032023-05-032022-04-020923-7534http://hdl.handle.net/10668/21893enPhase IIIb study of durvalumab plus platinumeetoposide in first-line treatment of extensive-stage small cell lung cancer (CANTABRICO): Treatment patterns of chemotherapy combination phase with durvalumabconference outputopen access10.1016/j.annonc.2022.02.1731569-8041http://www.annalsofoncology.org/article/S0923753422002897/pdf778453100144